Steven Romano News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)

Study met primary endpoint and demonstrated highly significant reductions in Lp to week 36 Lipoprotein reduction was consistent with phase 1 results Topline 48-week data expected in 2Q 2024 .

Steven romanoHansoh pharmaHead of researchExchange commission onSilence therapeuticsSecurities litigation reform actAdmission documentAnnual reportExchange commission

Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments

Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomSantaris pharmaSteven romanoMarie wikstrCurtis rambaranHansoh pharmaHead of researchExchange commission onMallinckrodt pharmaceuticalsExpert scientist in discovery technologyCorporate communicationsUppsala universityUniversity of the west indiesChief medicalChief scientificVice president

Silence Therapeutics plc: Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments

Silence Therapeutics plc: Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomHansoh pharmaSantaris pharmaMarie wikstrStefan klotterCurtis rambaranSteven romanoMallinckrodt pharmaceuticalsExpert scientist in discovery technologyCorporate communicationsHead of researchUniversity of the west indiesUppsala universityExchange commission onChief medicalChief scientific

Silence Therapeutics Appoints Dr Steven Romano as Incoming Chief Medical Officer and Head of Research and Development

Silence Therapeutics Appoints Dr Steven Romano as Incoming Chief Medical Officer and Head of Research and Development
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eli lillyGiles campionHansoh pharmaSteven romanoCraig toomanExchange commissionHead of researchGlobal innovative pharmaceuticals businessMallinckrodt pharmaceuticalsCorporate communicationsCornell medical centerUniversity of missouriWashington university in stGlobal medicines developmentChief medical officerSilence board

Silence Therapeutics plc: Silence Therapeutics Appoints Dr Steven Romano as Incoming Chief Medical Officer and Head of Research and Development

Dr. Romano will succeed Dr. Giles Campion, CMO and Head of R&D, following his retirement by year-end Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative

Eli lillyGiles campionHansoh pharmaCraig toomanSteven romanoGlobal medicines developmentWashington university in stUniversity of missouriCornell medical centerCorporate communicationsHead of researchExchange commissionMallinckrodt pharmaceuticalsGlobal innovative pharmaceuticals businessChief medical officerSilence board